Tulsa | Oklahoma | 2022 | Market Overview Brief

In the wake of the COVID-19 pandemic, health systems in Tulsa continue to pursue expansion projects that will increase access to services and intensify competition within the provider sector. Health systems are targeting lucrative specialty care, such as oncology, as well as more cost-effective, convenient care, such as ambulatory surgery centers, for growth. These expansions could drive higher levels of medical utilization, including drug utilization. Physician groups are also deploying telehealth solutions such as virtual visits to maintain access to care and are beginning to distribute COVID-19 vaccines. In the payer sector, Blue Cross and Blue Shield of Oklahoma, Humana, UnitedHealthcare, and a subsidiary of Centene have won contracts for managing Oklahoma’s Medicaid program. As the state moves forward with managed Medicaid, it will also expand the program to an estimated 272,000 residents, which could improve the outlook for drug sales.

Login to access report